The mechanisms of cancer immunoescape and development of overcoming strategies
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-03-01
著者
-
KAWAKAMI Yutaka
Division of Cellular Signaling, Institute for Advanced Medical Research
-
Sumimoto Hidetoshi
Division Of Cellular Signaling Institute For Advanced Medical Research Keio University School Of Med
-
Kawakami Yutaka
Division Of Cellular Signaling Institute For Advanced Medical Research
-
Yaguchi Tomonori
Division Of Cellular Signaling Institute For Advanced Medical Research Keio University School Of Med
-
Kawamura Naoshi
Division Of Cellular Signaling Institute For Advanced Medical Research Keio University School Of Med
-
Kawakami Yutaka
Division Of Cellular Signaling Institute For Advanced Medical Research Keio University School Of Med
-
Kawamura Naoshi
Division Of Cellular Signaling Institute For Advanced Medical Research
-
Yaguchi Tomonori
Division Of Cellular Signaling Institute For Advanced Medical Research
-
Kudo Saito
Division Of Cellular Signaling Institute For Advanced Medical Research
-
Sumimoto Hidetoshi
Division Of Cellular Signaling Institute For Advanced Medical Research
-
Iwata Kajihara
Division Of Cellular Signaling Institute For Advanced Medical Research
-
TSUKAMOTO Nobuo
Division of Cellular Signaling, Institute for Advanced Medical Research
-
UEDA Ryo
Division of Cellular Signaling, Institute for Advanced Medical Research
-
NISHIO Hiroshi
Division of Cellular Signaling, Institute for Advanced Medical Research
-
Tsukamoto Nobuo
Division Of Cellular Signaling Institute For Advanced Medical Research
-
Ueda Ryo
Division Of Cellular Signaling Institute For Advanced Medical Research
-
Nishio Hiroshi
Division Of Cellular Signaling Institute For Advanced Medical Research
関連論文
- Blast Phase of Chronic Myeloid Leukemia Presenting Lymphoid Phenotype with a Chronic Phase of Extremely Short Duration
- Inflammation and pathogenic fibrosis in human ocular chronic graft versus host disease
- Identification of Human Tumor Antigens Recognized by T-Cells and Their Use for Immunotherapy
- Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
- Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients
- Immunotherapy of Melanoma Using T Cell Defined Antigens
- Development of Immunotherapy for Pancreatic Cancer
- Simultaneous suppression of MITF and BRAF^ enhanced inhibition of melanoma cell proliferation
- Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
- Immunotherapy Using T Cell Defined Tumor Antigens for Melanoma
- IDENTIFICATION OF HUMAN MELANOMA ANTIGENS RECOGNIZED BY TUMOR INFILTRATING T LYMPHOCYTES AND THEIR USE FOR IMMUNOTHERAPY
- The mechanisms of cancer immunoescape and development of overcoming strategies